You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • AB0390 Efficacy and safety of yisaipu, a recombinant human tumor necrosis factor-α receptor II IGG FC fusion protein in chinese patients with moderate to severe rheumatoid arthritis

Citation Tools

Article menu

Download PDFPDF

Abstracts Accepted for Publication
Rheumatoid arthritis - anti-TNF therapy
AB0390 Efficacy and safety of yisaipu, a recombinant human tumor necrosis factor-α receptor II IGG FC fusion protein in chinese patients with moderate to severe rheumatoid arthritis
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Wu R
AB0390 Efficacy and safety of yisaipu, a recombinant human tumor necrosis factor-α receptor II IGG FC fusion protein in chinese patients with moderate to severe rheumatoid arthritis
Annals of the Rheumatic Diseases 2017;76:1185.